Skip to main content

Pathways to Work

Volume 458: debated on Wednesday 14 March 2007

To ask the Secretary of State for Work and Pensions how many people have been subject to mandatory work-focused interviews as part of the Pathways to Work pilots since their inception; and in how many cases such an interview has been waived in the case of people with (a) certain infectious and parasitic diseases, (b) neoplasms, (c) diseases of the blood and blood forming organs and certain diseases involving the immune mechanism, (d) endocrine, nutritional and metabolic diseases, (e) mental and behavioural disorders, (f) diseases of the nervous system, (g) diseases of the eye and adnexa, (h) diseases of the ear and mastoid process, (i) diseases of the circulatory system, (j) diseases of the respiratory system, (k) factors influencing health status and contact with health services, (l) diseases of the digestive system, (m) diseases of the skin and subcutaneous system, (n) diseases of the musculoskeletal system and connective tissue, (o) diseases of the genitourinary system, (p) pregnancy, childbirth and the puerperium, (q) certain conditions originating in the perinatal period, (r) congenital malformations, deformations and chromosomal abnormalities, (s) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified and (t) injury, poisoning and certain other consequences of external causes. (101745)

114,430 new incapacity benefit customers have been subject to mandatory work focused interviews as part of Pathways to Work. Of these, 9,050 had their initial work focused interviews waived.

26,580 incapacity benefit customers who are part of the extension of Pathways to existing customers have been subject to mandatory work focused interviews. Of these, 7,580 have had their work focused interviews waived.

The breakdown of waivers by condition type is in the following table:

Mandated new incapacity benefit customers

Mandatory extension to existing customers

Certain Infectious and Parasitic Diseases

50

30

Neoplasms

660

110

Diseases of the blood

10

10

Endocrine, Nutritional and Metabolic Diseases

60

110

Mental and Behavioural Disorders

1,830

2,530

Diseases of the Nervous System

290

320

Diseases of the Eye and Adnexa

30

20

Diseases of the Ear and Mastoid Process

10

30

Diseases of the Circulatory System

340

430

Diseases of the Respiratory System

140

190

Diseases of the Digestive System

100

110

Diseases of the Skin and Subcutaneous Tissue

30

30

Diseases of the Musculoskeletal system and Connective Tissue

590

1,440

Diseases of the Genitourinary System

60

50

Pregnancy, Childbirth and the Puerperium

50

10

Congenital Malformations and Deformations

10

0

Symptoms, Signs and Abnormal Clinical and Laboratory findings

510

770

Injury Poisoning and other consequences of external causes

260

280

Hospital investigations, treatment, observation

100

60

Radiotherapy, Chemotherapy (with cytotoxic drugs)

70

10

Acquired absence of limb

10

10

Not Yet Diagnosed

0

0

Surgical Treatment

130

120

Terminally ill

0

0

Unknown

3,720

920

Total

9,050

7,580

Note:

All figures have been rounded to the nearest 10.

Source:

Pathways to Work Evaluation Database (data to the end of June 2006)

To ask the Secretary of State for Work and Pensions what improvement in employment outcomes has taken place in the Pathways to Work pilot areas for (a) all participants, (b) participants over 50 years, (c) participants whose first reason for claiming incapacity is mental ill-health and (d) all participants with mental ill-health. (106414)

[holding answer 30 November 2006]: Information is not available in the format requested. However, early findings from the independent research conducted by the Institute for Fiscal Studies (Early quantitative evidence on the impact of the Pathways to Work pilots, DWP Research Report No. 354), shows for all participants a 9.5 per cent. increase in the proportion of people who are employed 10 and a half months after claiming incapacity benefit. For participants over the age of 45, the increase in the proportion of people who are employed 10 and a half months after claiming incapacity benefit was 12 per cent.

For participants whose health problem is a mental health condition, there has been no significant impact on the proportion of people who are employed 10 and a half months after claiming incapacity benefit.

Our internal analysis has found that in terms of the net impact of Pathways to Work, those with a mental health or behavioural disorder have fared as well as other customers in terms of off-flows from benefit. One-to-one research with personal advisers and practitioners has found many examples of incapacity benefit customers helped by our Condition Management Pathways in Pathways areas.